By identifying Fam20c as a key molecular switch in adipocyte dysfunction, our findings provide insights into the mechanisms driving obesity-related metabolic diseases and offer potential therapeutic avenues for preventing or treating T2D. Here, FAM20C is linked to metabolic disease.